Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
暂无分享,去创建一个
[1] C. Serhan,et al. Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells. , 2002, Advances in experimental medicine and biology.
[2] C. Serhan,et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. , 2001, The American journal of pathology.
[3] R. Bolli,et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Levy,et al. Oxidoreductases in Lipoxin A4 Metabolic Inactivation , 2000, The Journal of Biological Chemistry.
[5] S. Abraham,et al. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis , 2000, Journal of leukocyte biology.
[6] J. Bolognese,et al. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group. , 2000, Arthritis and rheumatism.
[7] C. Serhan,et al. IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Serhan,et al. Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation , 2000, The Journal of experimental medicine.
[9] C. Clish,et al. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. , 2000, Biochemistry.
[10] J. Varga,et al. Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of Metalloproteinases1 , 2000, The Journal of Immunology.
[11] Hugh R. Brady,et al. Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.
[12] C. Serhan,et al. Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1 , 2000, The Journal of Immunology.
[13] C. Serhan,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Anti-Inflammatory Actions of Lipoxin A 4 Stable Analogs Are Demonstrable in Human Whole Blood: Modulation of Leukocyte Adhesion Molecules and Inhibition of Neutrophil-Endothelial Interactions , 2016 .
[14] C. Serhan,et al. Identification of a human enterocyte lipoxin a receptor that is regulated by IL-13 and IFN-γ and inhibits TNF-α-induced IL-8 release , 1999 .
[15] K. Ley,et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. , 1999, Science.
[16] M. Freeman,et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. , 1999, The Journal of clinical investigation.
[17] C. Clish,et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo , 1999 .
[18] G. Weissmann,et al. Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFkappaB knockout mice. , 1999, Osteoarthritis and cartilage.
[19] C. Serhan,et al. Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis , 1999, The Journal of experimental medicine.
[20] G. Weissmann,et al. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Serhan,et al. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. , 1999, American journal of physiology. Cell physiology.
[22] C. Godson,et al. Regulation of Leukocyte Trafficking by Lipoxins , 1999, Clinical chemistry and laboratory medicine.
[23] C. Clish,et al. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. , 1998, The Journal of pharmacology and experimental therapeutics.
[24] W. Jiménez,et al. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. , 1998, Gastroenterology.
[25] H. Herschman. Recent progress in the cellular and molecular biology of prostaglandin synthesis. , 1998, Trends in cardiovascular medicine.
[26] C. Clish,et al. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[28] J. Mancini,et al. Suppression of Leukotriene B4 Biosynthesis by Endogenous Adenosine in Ligand-activated Human Neutrophils , 1997, The Journal of experimental medicine.
[29] T. Takano,et al. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.
[30] G. Levy. Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] M. H. Lee,et al. Aspirin-Triggered Lipoxins (15-epi-LX) Are Generated by the Human Lung Adenocarcinoma Cell Line (A549)–Neutrophil Interactions and Are Potent Inhibitors of Cell Proliferation , 1996, Molecular medicine.
[32] E. Tagaya,et al. Lipoxin A4 inhibits cholinergic neurotransmission through nitric oxide generation in the rabbit trachea. , 1995, European journal of pharmacology.
[33] M. Savage,et al. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II) , 1995, Circulation.
[34] I. Akritopoulou‐Zanze,et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.
[35] C. Serhan,et al. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Marcus. Aspirin as prophylaxis against colorectal cancer. , 1995, The New England journal of medicine.
[37] J. Morrow,et al. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. , 1994, The Journal of biological chemistry.
[38] J. Lindgren,et al. Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis. , 1994, Leukemia research.
[39] H. Lehr,et al. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Serhan. Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.
[41] J. Drazen,et al. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. , 1993, The Journal of clinical investigation.
[42] C. Serhan,et al. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. , 1993, The Journal of clinical investigation.
[43] John I. Gallin,et al. Inflammation: Basic Principles and Clinical Correlates , 1992 .
[44] C. Serhan,et al. Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin. , 1992, Biochemical and biophysical research communications.
[45] C. Serhan,et al. Angioplasty Triggers Intracoronary Leukotrienes and Lipoxin A4: Impact of Aspirin Therapy , 1992, Circulation.
[46] J. Lindgren,et al. Formation and proliferative effects of lipoxins in human bone marrow. , 1991, Biochemical and biophysical research communications.
[47] J. Lindgren,et al. On the mechanism of transcellular lipoxin formation in human platelets and granulocytes. , 1991, European journal of biochemistry.
[48] J. Palmblad,et al. Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.
[49] J. Lindgren,et al. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. , 1991, Blood.
[50] J. Lindgren,et al. Lipoxin formation in human nasal polyps and bronchial tissue , 1990, FEBS letters.
[51] C. Serhan,et al. Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. , 1990, The Journal of clinical investigation.
[52] B. Spur,et al. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. , 1989, Clinical science.
[53] C. Serhan,et al. Phospholipid bilayers enhance the stability of leukotriene A4 and epoxytetraenes: stabilization of eicosanoids by liposomes. , 1989, Biochemical and biophysical research communications.
[54] S. Dahlén,et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.
[55] B. Samuelsson. FROM STUDIES OF BIOCHEMICAL MECHANISMS TO NEW BIOLOGICAL MEDIATORS: PROSTAGLANDIN ENDOPEROXIDES, THROMBOXANES, AND LEUKOTRIENES , 1984 .
[56] Nobelstiftelsen. Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures , 1982 .